Type 1 diabetes vaccine candidates promote human Foxp3+Treg induction in humanized mice
Type 1 diabetes is associated with the loss of self-tolerance to the insulin-producing β-cells in the pancreas. Here the authors show that vaccination with insulin mimetopes can induce human insulin-specific regulatory T cells to mediate tolerance in a humanized mouse model.
Main Authors: | Isabelle Serr, Rainer W. Fürst, Peter Achenbach, Martin G. Scherm, Füsun Gökmen, Florian Haupt, Eva-Maria Sedlmeier, Annette Knopff, Leonard Shultz, Richard A. Willis, Anette-Gabriele Ziegler, Carolin Daniel |
---|---|
Format: | Article |
Language: | English |
Published: |
Nature Publishing Group
2016-03-01
|
Series: | Nature Communications |
Online Access: | https://doi.org/10.1038/ncomms10991 |
Similar Items
-
Advances in Human Immune System Mouse Models for Personalized Treg-Based Immunotherapies
by: Isabelle Serr, et al.
Published: (2021-02-01) -
FOXP3 promoter demethylation reveals the committed Treg population in humans.
by: Peter C J Janson, et al.
Published: (2008-01-01) -
Antigen-Specific Treg Therapy in Type 1 Diabetes – Challenges and Opportunities
by: Isabelle Serr, et al.
Published: (2021-07-01) -
A Study of CD4+Foxp3+Treg and CD8+Foxp3+Treg Cells in Patients with Rheumatoid Arthritis
by: Mahtab Tapak, et al.
Published: (2011-11-01) -
CD80 on Human T Cells Is Associated With FoxP3 Expression and Supports Treg Homeostasis
by: Blagoje Soskic, et al.
Published: (2021-01-01)